HuGE Literature Finder
Records 1-30
|
BRAF V600E Mutation in First-line Metastatic Colorectal Cancer: an Analysis of Individual Patient Data from the ARCAD Database.
Journal of the National Cancer Institute 2021 Mar . Cohen Romain, Liu Heshan, Fiskum Jack, Adams Richard, Chibaudel Benoist, Maughan Timothy S, Van Cutsem Eric, Venook Alan, Douillard Jean-Yves, Heinemann Volker, Punt Cornelis J A, Falcone Alfredo, Bokemeyer Carsten, Kaplan Richard, Lenz Heinz-Josef, Koopman Miriam, Yoshino Takayuki, Zalcberg John, Grothey Alex, de Gramont Aimery, Shi Qian, André Thier |
|
Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer.
Clinical biochemistry 2021 Mar . Huang Fei, Yang Yihui, Chen Xinning, Jiang Huiqin, Wang Hao, Shen Minna, Yu Yiyi, Liu Tianshu, Pan Baishen, Wang Beili, Guo W |
|
Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
Scientific reports 2021 Mar 11 (1): 6203. Lee Sun Mi, Sung Chang O |
|
Histological growth patterns and molecular analysis of resected colorectal lung metastases.
Pathology, research and practice 2021 Mar 222 153414. Pilozzi Emanuela, Fedele Damiano, Montori Andrea, Lorenzon Laura, Peritore Valentina, Mannocchi Giorgia, Bagheri Nikta, Leone Chiara, Palumbo Antonio, Roberto Michela, Ranazzi Giulio, Rendina Erino, Balducci Genoveffa, Ibrahim Mohs |
|
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.
ESMO open 2021 Mar 6 (2): 100062. Sastre J, García-Alfonso P, Viéitez J M, Cano M T, Rivera F, Reina-Zoilo J J, Salud-Salvia A, Quintero G, Robles-Díaz L, Safont M J, La Casta A, Gil S, Polo E, Asensio-Martínez E, García-Paredes B, López R L, Guillot M, Valladares-Ayerbes M, Aranda E, Díaz-Rubio E, |
|
[Analysis of influencing factors of KRAS/NRAS/BRAF/PIK3CA gene mutation consistency in patients with advanced colorectal cancer].
Zhonghua yi xue za zhi 2021 Feb 101 (6): 400-404. Jiang H Q, Wang B L, Guo |
|
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
Targeted oncology 2021 Feb . Wong Vanessa, Lee Margaret, Wong Rachel, Tie Jeanne, Shapiro Jeremy, Desai Jayesh, Nott Louise, Steel Simone, Burge Matthew, Ma Brigette, Khattak Adnan, Hong Wei, Gibbs Pet |
|
Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China.
Current medical science 2021 Feb 41 (1): 118-126. Chang Xiao-Na, Shang Fu-Mei, Jiang Hong-Yu, Chen Chen, Zhao Zhe-Yan, Deng Sheng-He, Fan Jun, Dong Xiao-Chuan, Yang Ming, Li Yan, Cai Kai-Lin, Liu Li, Liu Hong-Li, Nie X |
|
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
BMC cancer 2021 Jan 21 (1): 64. Martínez-Lago Nieves, Fernández-Montes Ana, Covela Marta, Brozos Elena M, De la Cámara Juan, Méndez Méndez José C, Jorge-Fernández Mónica, Cousillas Castiñeiras Antía, Reboredo Cristina, Arias Ron David, Pellón Augusto María L, González Villarroel Paula, Graña Begoña, Salgado Fernández Mercedes, Carral Maseda Alberto, Vázquez Rivera Francisca, Candamio Folgar Sonia, Reboredo López Margarita, |
|
Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis.
Frontiers in oncology 2021 11 643136. Mo Shaobo, Wang Hui, Han Lingyu, Xiang Wenqiang, Dai Weixing, Zhao Pengfei, Pei Fengchun, Su Zhixi, Ma Chengcheng, Li Qi, Wang Zhimin, Cai Sanjun, Wang Hao, Liu Rui, Cai Guoxia |
|
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of Tissue/Plasma Discordant Cases.
Journal of clinical medicine 2020 Dec 10 (1): . Formica Vincenzo, Lucchetti Jessica, Doldo Elena, Riondino Silvia, Morelli Cristina, Argirò Renato, Renzi Nicola, Nitti Daniele, Nardecchia Antonella, Dell'Aquila Emanuela, Ferroni Patrizia, Guadagni Fiorella, Palmieri Giampiero, Orlandi Augusto, Roselli Mar |
|
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway.
Clinical colorectal cancer 2020 Dec . Chuang Jeremy, Wang Chongkai, Guo Yuming, Valenzuela Valerie, Wu Jun, Fakih Marw |
|
The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
Journal of surgical oncology 2020 Dec . Kamphues Carsten, Kadowaki Shigenori, Amini Neda, van den Berg Inge, Wang Jaeyun, Andreatos Nikolaos, Sakamoto Yuki, Ogura Toshiro, Kakuta Miho, Pikouli Anastasia, Geka Despoina, Daitoku Nobuya, Theochari Maria, Buettner Stefan, Akiyama Takahiko, Antoniou Efstathios, Pikoulis Emmanouil, Theodoropoulos George, Imai Katsunori, Ijzermans Jan N M, Margonis Georgios A, Akagi Kiwamu, Kreis Martin |
|
The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients.
British journal of cancer 2020 Nov . Jácome Alexandre A, Vreeland Timothy J, Johnson Benny, Kawaguchi Yoshikuni, Wei Steven H, Nancy You Y, Vilar Eduardo, Vauthey Jean-Nicolas, Eng Cat |
|
Wild-type APC is associated with poor survival in metastatic microsatellite stable colorectal cancer.
The oncologist 2020 Nov . Wang Chongkai, Ouyang Ching, Cho May, Ji Jingran, Sandhu Jaideep, Goel Ajay, Kahn Michael, Fakih Marw |
|
Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Oct . Loree Jonathan M, Dowers Anthony, Tu Dongsheng, Jonker Derek, Edelstein Daniel L, Quinn Hannah, Holtrup Frank, Price Timothy, Zalcberg John R, Moore Malcolm J, Karapetis Christos S, O'Callaghan Chris J, Waring Paul, Kennecke Hagen F, Hamilton Stanley R, Kopetz Sco |
|
Frequency and Coexistence of KRAS, NRAS, BRAF, and PIK3CA Mutations and occurrence of MMR deficiency in Danish Colorectal Cancer Patients.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2020 Oct . Poulsen Tim Svenstrup, de Oliveira Douglas Vinicius Nogueira Perez, Espersen Maiken Lise Marcker, Klarskov Louise Laurberg, Skovrider-Ruminski Wojciech, Hogdall Estr |
|
Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype Correlation.
International journal of surgical pathology 2020 Oct 1066896920963798. Brcic Iva, Dawson Heather, Gröchenig Hans Peter, Högenauer Christoph, Kashofer Ka |
|
Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis of 9 studies.
Cancer research 2020 Aug . Hidaka Akihisa, Harrison Tabitha A, Cao Yin, Sakoda Lori C, Barfield Richard, Giannakis Marios, Song Mingyang, Phipps Amanda I, Figueiredo Jane C, Zaidi Syed H, Toland Amanda E, Amitay Efrat L, Berndt Sonja I, Borozan Ivan, Chan Andrew T, Gallinger Steven, Gunter Marc J, Guinter Mark A, Harlid Sophia, Hampel Heather, Jenkins Mark A, Lin Yi, Moreno Victor, Newcomb Polly A, Nishihara Reiko, Ogino Shuji, Obón-Santacana Mireia, Parfrey Patrick S, Potter John D, Slattery Martha L, Steinfelder Robert S, Um Caroline Y, Wang Xiaoliang, Woods Michael O, Van Guelpen Bethany, Thibodeau Stephen N, Hoffmeister Michael, Sun Wei, Hsu Li, Buchanan Daniel D, Campbell Peter T, Peters Ulri |
|
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer.
Current problems in cancer 2020 Aug 100637. Prasanna Thiru, Wong Rachel, Price Timothy, Shapiro Jeremy, Tie Jeanne, Wong Hui-Li, Nott Louise, Roder David, Lee Margaret, Kosmider Suzanne, Jalali Azim, Burge Matthew, Padbury Robert, Maddern Guy, Carruthers Scott, Moore James, Sorich Michael, Karapetis Christos S, Gibbs Peter, Yip Desmo |
|
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
European journal of cancer (Oxford, England : 1990) 2020 Aug 137 250-259. Stahler Arndt, Stintzing Sebastian, von Einem Jobst C, Westphalen Christoph B, Heinrich Kathrin, Krämer Nicole, Michl Marlies, Modest Dominik P, von Weikersthal Ludwig Fischer, Decker Thomas, Kiani Alexander, Heintges Tobias, Kahl Christoph, Kullmann Frank, Scheithauer Werner, Moehler Markus, Kaiser Florian, Kirchner Thomas, Jung Andreas, Heinemann Volk |
|
Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2020 Jul 42 (7): 1010428320938492. Wielandt Ana María, Hurtado Claudia, Moreno C Mauricio, Villarroel Cynthia, Castro Magdalena, Estay Marlene, Simian Daniela, Martinez Maripaz, Vial Maria Teresa, Kronberg Udo, López-Köstner Francis |
|
EFFECTIVENESS OF FIRST-LINE CETUXIMAB IN WILD-TYPE RAS METASTATIC COLORECTAL CANCER ACCORDING TO TUMOUR BRAF MUTATION STATUS FROM THE EREBUS COHORT.
British journal of clinical pharmacology 2020 Jul . Rouyer Magali, Francois Eric, Sa Cunha Antonio, Monnereau Alain, Bignon Emmanuelle, Jove Jérémy, Lassalle Régis, Droz-Perroteau Cécile, Moore Nicholas, Noize Pernelle, Fourrier-Réglat Annie, Smith Denis, |
|
Nut and peanut butter intake and the risk of colorectal cancer and its anatomical and molecular subtypes: the Netherlands Cohort Study.
Carcinogenesis 2020 Jul . Nieuwenhuis Lisette, Simons Colinda C J M, Weijenberg Matty P, van den Brandt Piet |
|
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.
Clinical colorectal cancer 2020 Mar . Kasper Stefan, Meiler Johannes, Knipp Heike, Höhler Thomas, Reimer Peter, Steinmetz Tilman, Berger Winfried, Linden Gabriele, Reis Henning, Markus Peter, Paul Andreas, Dechêne Alexander, Schumacher Brigitte, Kostbade Karina, Virchow Isabel, Ting Saskia, Worm Karl, Schmid Kurt W, Herold Thomas, Wiesweg Marcel, Schuler Martin, Trarbach Tan |
|
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer.
Frontiers in oncology 2020 10 568911. Xu Ting, Zhang Yinjie, Zhang Jing, Qi Changsong, Liu Dan, Wang Zhenghang, Li Yanyan, Ji Congcong, Li Jian, Lin Xuan, Hou Ting, Liu Hao, Zhang Lu, Han-Zhang Han, Shen Lin, Wang Xiche |
|
KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis.
Caspian journal of internal medicine 2020 11 (4): 355-369. Yari Abolfazl, Afzali Asiyeh, Aalipour Mostafa, Nakheai Mehran, Zahedi Mohammad Jav |
|
KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.
PloS one 2020 15 (7): e0235490. Sanchez-Ibarra Hector Eduardo, Jiang Xianli, Gallegos-Gonzalez Elena Yareli, Cavazos-González Adriana Carolina, Chen Yenho, Morcos Faruck, Barrera-Saldaña Hugo Alber |
|
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer.
JCO precision oncology 2019 3 . Johnson Benny, Loree Jonathan M, Jacome Alexandre A, Mendis Shehara, Syed Muddassir, Morris Ii Van K, Parseghian Christine M, Dasari Arvind, Pant Shubham, Raymond Victoria M, Vilar Eduardo, Overman Michael, Kee Bryan, Eng Cathy, Raghav Kanwal, Kopetz Sco |
|
[Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 0 54 (1): 41-54. Navarro Samuel, Cuatrecasas Miriam, Hernández-Losa Javier, Landolfi Stefania, Musulén Eva, Ramón Y Cajal Santiago, García-Carbonero Rocío, García-Foncillas Jesús, Pérez-Segura Pedro, Salazar Ramón, Vera Ruth, García-Alfonso Pil |
- Page last reviewed:Oct 1, 2020
- Page last updated:May 12, 2021
- Content source: